Developing an effective inhibitor of the alternative pathway of complement (APC) with potential for safe clinical use is a daunting undertaking, but Fridkis-Hareli and colleagues were up for the challenge.
CITATION STYLE
Parker, C. (2011, October 27). Thanks for the complement (inhibitor). Blood. American Society of Hematology. https://doi.org/10.1182/blood-2011-09-377309
Mendeley helps you to discover research relevant for your work.